跳转至内容
Merck
CN

SML1409

Sigma-Aldrich

Madrasin

≥98% (HPLC)

登录查看公司和协议定价

别名:
2-[((7-甲氧基-4-甲基-2-喹唑啉基)氨基] -5,6-二甲基-4(1H)-嘧啶酮(9CI), 2-(7-甲氧基-4-甲基-喹唑啉-2-基氨基)-5,6-二甲基-3H-嘧啶-4-酮, 4(1H)-嘧啶酮,2-[((7-甲氧基-4-甲基-2-喹唑啉基)氨基] -5,6-二甲基-(9CI), 4(3H)-嘧啶酮,2-[((7-甲氧基-4-甲基-2-喹唑啉基)氨基] -5,6-二甲基-, DDD00107587, RNA剪接抑制剂
经验公式(希尔记法):
C16H17N5O2
分子量:
311.34
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77

质量水平

检测方案

≥98% (HPLC)

形式

powder

颜色

, white to dark brown

溶解性

DMSO: 0.5 mg/mL, clear (warmed)

储存温度

2-8°C

SMILES字符串

CC1=NC(NC(NC(C)=C2C)=NC2=O)=NC3=CC(OC)=CC=C31

InChI

1S/C16H17N5O2/c1-8-9(2)17-16(20-14(8)22)21-15-18-10(3)12-6-5-11(23-4)7-13(12)19-15/h5-7H,1-4H3,(H2,17,18,19,20,21,22)

InChI key

QQJIYKXTEMDJFM-UHFFFAOYSA-N

应用

Madrasin已作为剪接体抑制剂,抑制3T3-L1细胞中前体RNA的剪接加工。

生化/生理作用

Madrasin 是一种高效的、细胞渗透性剪接抑制剂,可干扰剪接体组装的早期阶段。 Madrasin 使 A 复合体的剪接体装配停滞。
Madrasin在较高浓度下具有细胞毒性。在极低浓度下,Madrasin可诱导蛋白亚细胞核定位和引起细胞周期停滞。

象形图

Exclamation mark

警示用语:

Warning

危险声明

危险分类

Acute Tox. 4 Oral

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Andrea Pawellek et al.
The Journal of biological chemistry, 289(50), 34683-34698 (2014-10-05)
Eukaryotic pre-mRNA splicing is an essential step in gene expression for all genes that contain introns. In contrast to transcription and translation, few well characterized chemical inhibitors are available with which to dissect the splicing process, particularly in cells. Therefore
Yves Mugabo et al.
The Journal of biological chemistry, 293(18), 6736-6750 (2018-03-14)
Adipogenesis involves a complex signaling network requiring strict temporal and spatial organization of effector molecules. Molecular scaffolds, such as 14-3-3 proteins, facilitate such organization, and we have previously identified 14-3-3ζ as an essential scaffold in adipocyte differentiation. The interactome of
Andrey A Parkhitko et al.
PLoS genetics, 17(2), e1009354-e1009354 (2021-02-17)
The RB1 tumor suppressor is recurrently mutated in a variety of cancers including retinoblastomas, small cell lung cancers, triple-negative breast cancers, prostate cancers, and osteosarcomas. Finding new synthetic lethal (SL) interactions with RB1 could lead to new approaches to treating

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门